4425 studies found for:    "Depressive Disorder" [DISEASE]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Intervention: Drug: OPC-34712 + ADT
2 Recruiting A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Brexpiprazole;   Drug: Seroquel XR;   Drug: Placebo
3 Completed
Has Results
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
4 Completed
Has Results
Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
5 Recruiting Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Depression;   Depressive Disorder
Interventions: Genetic: GeneSight Psychotropic (GEN);   Genetic: Enhanced-GeneSight Psychotropic (E-GEN);   Other: Treatment as Usual (TAU)
6 Completed Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Placebo + ADT;   Drug: Brexpiprazole +ADT
7 Recruiting Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
Conditions: Major Depressive Disorder;   Major Depressive Disorder, Recurrent, Unspecified;   Major Depressive Disorder, Single Episode, Unspecified
Interventions: Drug: Escitalopram oxalate;   Device: transcranial direct current stimulation;   Other: Sham tDCS + Placebo Pill
8 Withdrawn Brain Imaging, Genetics and Treatment for Major Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Other: Citalopram
9 Completed Safety and Efficacy Study in Patients With Major Depressive Disorder
Conditions: Depressive Disorder;   Major Depressive Disorder (MDD);   Major Depressive Episode
Interventions: Drug: GSK163090 Tablets;   Drug: GSK163090 Placebo Tablets
10 Completed Study Of GW679769 In Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
11 Completed Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
12 Terminated Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Conditions: Major Depressive Disorder;   Major Depressive Disorder w/ Psychotic Features;   Metabolic Syndrome
Intervention:
13 Recruiting Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Treatment-resistant;   Depressive Disorder, Major
Intervention: Device: LFMS
14 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
15 Completed Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder
Conditions: Current Major Depressive Disorder;   Healthy;   Remitted Major Depressive Disorder
Intervention:
16 Recruiting Glutamate Probes in Adolescent Depression
Conditions: Major Depressive Disorder;   Major Depressive Disorder, Recurrent;   Major Depressive Disorder, Remitted
Intervention:
17 Recruiting Study to Treat Major Depressive Disorder (MDD) With a New Medication
Conditions: Major Depressive Disorder;   Depression
Intervention: Drug: ezogabine
18 Completed A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Drug: risperidone
19 Terminated Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder
Conditions: Depression;   Depressive Disorder
Interventions: Device: Cortical Stimulation;   Device: Sham
20 Completed N-methylglycine (Sarcosine) Treatment for Depression
Conditions: Major Depressive Disorder;   Depression;   Major Depression
Interventions: Drug: citalopram;   Drug: sarcosine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years